News

Workhorse Group Inc. Achieves Progress in 2024 Financials

Workhorse Group Inc. Achieves Progress in 2024 Financials

Workhorse Group's Financial Results for 2024

CINCINNATI — Workhorse Group Inc. (NASDAQ: WKHS), a leader in zero-emission commercial vehicle technology, has reported its financial outcomes for the year ending December 31, 2024. The company has continued its mission to pioneer electric vehicles while responding to evolving market demands.

Management Insight

CEO Rick Dauch shared, "In the past year, our focus on enhancing our electric vehicle offerings has led to significant advancements. A notable achievement was obtaining approval from Transport Canada for our W4 CC and W56 models, enabling us to enter a new market arena. We anticipate demonstrating these trucks in Canada starting in April 2025. The launch of our extended W56 model emphasizes our commitment to catering to customer requirements, as it features improved cargo capacity designed for complex delivery routes, simulating over 250,000 miles of durability tests. Our efforts have already yielded a purchase order for 13 vehicles from a national workplace supplies provider, in partnership with Revolv, with deliveries expected in the second quarter of 2025."

Strategic Acquisitions and Retaining Financial Stability

The company secured a General Services Administration (GSA) contract, simplifying procurement for federal government agencies looking to procure Workhorse vehicles. This focus on strategic partnerships is complemented by a Sourcewell agreement which led to sales of the W4 CC to the City of Tacoma. Workhorse is actively nurturing its dealer network to enhance the availability of electric commercial vehicles in specialized fleets.

Expanding Customer Networks

Throughout 2024, Workhorse established a stronger customer base with notable sales, including contracts secured for 13 step vans from a national supplier. This was a shift in direction following the positive feedback on the extended wheelbase trucks. In addition, the California Department of Government Services awarded a contract to Kingsburg Truck Center to procure Workhorse's W4 CC and W56 models. Several independent delivery service providers have also placed orders, indicating growing confidence in the reliability of Workhorse's products.

Financial Overview for 2024

Workhorse experienced a decline in sales, with net sales at $6.6 million in 2024 compared to $13.1 million in 2023. The decrease was attributed to lower sales of the W4 CC trucks, although W56 truck sales exhibited resilience.

Cost Management Initiatives

The company recorded cost of sales at $28.2 million, a reduction from $38.4 million in 2023, driven by lower sales of W4 CC vehicles and cost-saving measures that resulted in significant financial savings across various expense categories. Measures included reducing employee costs and streamlining inventory and consulting expenses.

Research and Development Efforts

Investments in research and development totaled $9.1 million in 2024, down from $24.5 million in 2023. This reduction was largely due to decreased compensation for R&D staff and lower prototype-related expenses as Workhorse vertically integrated its production capabilities.

Challenges and Future Focus

The year concluded with a net loss of $101.8 million compared to a higher loss of $123.9 million the previous year. Despite the challenges, Workhorse remains optimistic about the long-term potential of the electric vehicle market.

Looking Ahead

CFO Bob Ginnan stated, "We have initiated various strategies to reduce costs, and we have successfully secured financing to bolster our operational liquidity. As we navigate current market challenges, our commitment to developing innovative solutions in the EV space remains strong. We will pursue every opportunity to ensure our objectives are met while sustaining our commitment to electric mobility."

Frequently Asked Questions

What are the financial results for Workhorse Group in 2024?

Workhorse Group reported net sales of $6.6 million for 2024, decreasing from $13.1 million in 2023.

What strategic contracts has Workhorse Group secured?

The company secured a GSA contract and successfully received purchase orders from government entities, including the City of Tacoma.

How did Workhorse Group manage costs in 2024?

Workhorse implemented cost-cutting measures that resulted in significant savings across various expense categories, including reduced employee costs and better inventory management.

What is the outlook for Workhorse Group?

Management maintains optimism regarding the electric vehicle market and focuses on sustaining its operations while enhancing their product offerings.

Where is Workhorse Group's manufacturing facility located?

Workhorse Group manufactures its vehicles in the U.S. at the Workhorse Ranch in Union City, Indiana.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Molina Healthcare: Anticipating Earnings and Market Movements

Updated Category News Views 138

Molina Healthcare's Upcoming Earnings Announcement Molina Healthcare (NYSE: MOH) is on the verge of releasing its quarterly earnings report, and investors are on high alert. The anticipated announcement will unfold on a Wednesday in the near future, and expectations are building around the company's performance. Understanding Earnings Expectations Analysts have projected...

Continue Reading
Innovative Sportswear Design Award by ANTA and Tsinghua University

Updated Category News Views 121

Introducing the 3rd Global Sportswear Design Award On an inspiring day in June, the 3rd Global Sportswear Design Award kicked off, marking a significant milestone in the world of sportswear design. This prestigious event, held at the China National Silk Museum, is a collaboration between ANTA Group and Tsinghua University. The central theme for this year's award is...

Continue Reading
Boeing's Speculation: What Lies Ahead for Its Stock?

Updated Category News Views 189

Understanding Boeing's Recent Stock Decline Boeing Company (NYSE: BA) shares experienced a noticeable drop recently. This decline followed a significant directive from the Federal Trade Commission (FTC) that requires Boeing to divest a considerable portion of its assets linked to Spirit Aerosystems Holdings, Inc. (NYSE: SPR). The market responded quickly, reflecting...

Continue Reading
Commitment to Recovery: Resilience in the Face of Disasters

Updated Category News Views 194

A Commitment to Community Resilience In recent times, our world has witnessed unprecedented weather events that remind us of the importance of community and resilient governance. Following a rare and intense rainfall that devastated many areas, community members are on the road to recovery, showcasing hope and togetherness. Devastation and Hope in Hard-Hit Regions In one...

Continue Reading
Eledon Pharmaceuticals Advances Tegoprubart for Kidney Care

Updated Category News Views 226

Exciting Advances in Kidney Transplant Rejection Prevention Recent findings from Eledon Pharmaceuticals, Inc. showcase significant results from the Phase 2 BESTOW trial, where Tegoprubart has emerged as a promising contender for preventing rejection in kidney transplant patients. Patients who continued on Tegoprubart for a year post-transplant revealed an impressive...

Continue Reading